Martingale Asset Management L P lifted its holdings in shares of Genpact Limited (NYSE:G) by 6.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 911,726 shares of the business services provider’s stock after purchasing an additional 57,532 shares during the period. Martingale Asset Management L P owned about 0.47% of Genpact worth $28,940,000 as of its most recent filing with the SEC.
Several other hedge funds have also added to or reduced their stakes in G. American International Group Inc. bought a new position in shares of Genpact during the 4th quarter valued at $114,000. Meeder Asset Management Inc. bought a new position in shares of Genpact during the 3rd quarter valued at $128,000. Advisor Group Inc. grew its holdings in shares of Genpact by 59.8% during the 3rd quarter. Advisor Group Inc. now owns 5,017 shares of the business services provider’s stock valued at $145,000 after purchasing an additional 1,878 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Genpact by 7.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock valued at $181,000 after purchasing an additional 455 shares during the last quarter. Finally, Verition Fund Management LLC bought a new position in shares of Genpact during the 2nd quarter valued at $210,000. 94.18% of the stock is currently owned by institutional investors.
Shares of Genpact Limited (NYSE:G) opened at $31.55 on Friday. The firm has a market cap of $6,066.28, a price-to-earnings ratio of 23.54, a price-to-earnings-growth ratio of 2.03 and a beta of 0.57. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.77. Genpact Limited has a 12-month low of $23.34 and a 12-month high of $34.79.
Genpact (NYSE:G) last posted its earnings results on Monday, February 12th. The business services provider reported $0.43 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.02. Genpact had a net margin of 9.61% and a return on equity of 23.53%. The firm had revenue of $734.41 million during the quarter, compared to analysts’ expectations of $723.55 million. During the same period last year, the company posted $0.43 EPS. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. equities research analysts expect that Genpact Limited will post 1.55 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 21st. Stockholders of record on Friday, March 9th will be given a $0.075 dividend. This represents a $0.30 annualized dividend and a dividend yield of 0.95%. This is a boost from Genpact’s previous quarterly dividend of $0.06. The ex-dividend date is Thursday, March 8th. Genpact’s dividend payout ratio (DPR) is currently 17.91%.
Several equities analysts recently commented on the stock. Zacks Investment Research lowered shares of Genpact from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th. Cantor Fitzgerald reissued a “buy” rating and set a $36.00 price target on shares of Genpact in a research report on Tuesday, February 13th. BMO Capital Markets increased their price target on shares of Genpact to $35.00 and gave the company a “market perform” rating in a research report on Tuesday, February 13th. Robert W. Baird reissued a “buy” rating and set a $38.00 price target on shares of Genpact in a research report on Friday, November 10th. Finally, Citigroup dropped their price target on shares of Genpact from $39.00 to $37.50 and set a “buy” rating for the company in a research report on Tuesday, February 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company. Genpact has a consensus rating of “Buy” and an average price target of $34.65.
In other news, Director James C. Madden sold 4,270 shares of the firm’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $30.92, for a total value of $132,028.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mohit Thukral sold 25,000 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $32.25, for a total transaction of $806,250.00. Following the completion of the sale, the insider now directly owns 85,305 shares of the company’s stock, valued at $2,751,086.25. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 164,934 shares of company stock valued at $5,346,881. Corporate insiders own 1.41% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This report was first reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.thelincolnianonline.com/2018/02/23/martingale-asset-management-l-p-acquires-57532-shares-of-genpact-limited-g.html.
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.